Intranasal immunization with vaccine vector Streptococcus gordonii elicits primed CD4+ and CD8+ T cells in the genital and intestinal tracts

Vaccine

Volumn 28, Issue 5, 2010, Pages 1226-1233

  Ciabattini, Annalisa ^a   Pettini, Elena ^a   Arsenijevic, Slavica ^a   Pozzi, Gianni ^a   Medaglini, Donata ^a  

^a UNIVERSITY OF SIENA   (Italy)

Author keywords

Mucosal vaccines; Streptococcus gordonii; T cell priming; Vaccine vectors

Indexed keywords

CD4 ANTIGEN; CD45RB ANTIGEN; CD8 ANTIGEN; HERMES ANTIGEN; L SELECTIN; STREPTOCOCCUS GORDONII VACCINE; STREPTOCOCCUS VACCINE; UNCLASSIFIED DRUG;

ADOPTIVE TRANSFER; ANIMAL EXPERIMENT; ANTIGEN EXPRESSION; ANTIGEN SPECIFICITY; ARTICLE; CELL DIVISION; CELL KINETICS; CELL MIGRATION; CERVICAL LYMPH NODE; CONTROLLED STUDY; FEMALE; GENITAL SYSTEM; IMMUNIZATION; IMMUNOMODULATION; INTESTINE; LYMPH NODE; LYMPHATIC DRAINAGE; LYMPHOCYTE CLONE; LYMPHOCYTE PROLIFERATION; MESENTERY LYMPH NODE; MOUSE; NONHUMAN; PRIORITY JOURNAL; SPLEEN; STREPTOCOCCUS GORDONII; T LYMPHOCYTE; TREATMENT OUTCOME;

ADMINISTRATION, INTRANASAL; ANIMALS; ANTIGENS; ANTIGENS, CD; CD4-POSITIVE T-LYMPHOCYTES; CD8-POSITIVE T-LYMPHOCYTES; CELL MOVEMENT; CELL PROLIFERATION; CERVIX UTERI; FEMALE; INTESTINES; LYMPH NODES; MICE; MICE, TRANSGENIC; SPLEEN; STREPTOCOCCUS GORDONII; TIME FACTORS;

EID: 74149091288     PISSN: 0264410X     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.vaccine.2009.11.021     Document Type: Article

References (64)

1. McHeyzer-Williams L.J., Pelletier N., Mark L., Fazilleau N., and McHeyzer-Williams M.G. Follicular helper T cells as cognate regulators of B cell immunity. Curr Opin Immunol 21 3 (2009) 266-273
2. + T cell response that predicts long-term persistence of protective antibody levels. Proc Natl Acad Sci USA 106 10 (2009) 3877-3882
3. Moon J.J., Chu H.H., Pepper M., McSorley S.J., Jameson S.C., Kedl R.M., et al. Naive CD4(+) T cell frequency varies for different epitopes and predicts repertoire diversity and response magnitude. Immunity 27 2 (2007) 203-213
4. Kearney E.R., Pape K.A., Loh D.Y., and Jenkins M.K. Visualization of peptide-specific T cell immunity and peripheral tolerance induction in vivo. Immunity 1 4 (1994) 327-339
5. Pettini E., Ciabattini A., Pozzi G., and Medaglini D. Adoptive transfer of transgenic T cells to study mucosal adjuvants. Methods 49 4 (2009) 340-345
6. + T cells following intranasal vaccination with recombinant bacteria. Infect Immun 76 12 (2008) 5817-5825
7. Johansen F.E., Baekkevold E.S., Carlsen H.S., Farstad I.N., Soler D., and Brandtzaeg P. Regional induction of adhesion molecules and chemokine receptors explains disparate homing of human B cells to systemic and effector sites: dispersion from tonsils. Blood 106 2 (2005) 593-600
8. Kiyono H., and Fukuyama S. NALT-versus Peyer's-Patch-mediated mucosal immunity. Nat Rev 4 9 (2004) 699-710
9. Moldoveanu A., Russel M.W., Wu H.Y., Huang W.Q., Compans R.W., and Mestecky J. Compartmentalization within the common mucosal immune system. Adv Exp Med Biol 371 (1995) 97-101
10. Wu H.Y., and Russel M.W. Nasal lymphoid tissue, intranasal immunization, and compartmentalization of the common mucosal immune system. Immunol Res 16 2 (1997) 187-201
11. Mestecky J., Moldoveanu Z., and Russell M.W. Immunologic uniqueness of the genital tract: challenge for vaccine development. Am J Reprod Immunol 53 (2005) 208-214
12. Wira C.R., Fahey J.V., Sentman C.L., Pioli P.A., and Shen L. Innate and adaptive immunity in female genital tract: cellular responses and interactions. Immunol Rev 206 (2005) 306-335
13. Lo Caputo S., Trabattoni D., Vichi F., Piconi S., Lopalco L., Villa M.L., et al. Mucosal and systemic HIV-1-specific immunity in HIV-1-exposed but uninfected heterosexual men. AIDS 17 4 (2003) 531-539
14. Kaul R., Plummer F., Clerici M., Bomsel M., Lopalco L., and Broliden K. Mucosal IgA in exposed, uninfected subjects: evidence for a role in protection against HIV infection. AIDS 15 3 (2001) 431-432
15. + CTLs in delay of AIDS viral dissemination from mucosa. Blood 15 107 (2006) 3258-3264
16. + T cell depletion during all stages of HIV disease occurs predominantly in the gastrointestinal tract. J Exp Med 200 6 (2004) 749-759
17. + T lymphocytes from effector sites in the gastrointestinal tract. J Exp Med 200 6 (2004) 761-770
18. + T cells in multiple tissues during acute SIV infection. Nature 434 7037 (2005) 1093-1097
19. Sankaran S., George M., Reay E., Guadalupe M., Flamm J., Prindiville T., et al. Rapid onset of intestinal epithelial barrier dysfunction in primary human immunodeficiency virus infection is driven by an imbalance between immune response and mucosal repair and regeneration. J Virol 82 1 (2008) 538-545
20. + T-cell depletion during acute and early human immunodeficiency virus type 1 infection. J Virol 81 2 (2006) 599-612
21. Zuercher A.W. Upper respiratory tract immunity. Viral Immunol 16 3 (2003) 279-289
22. Russel M.W., and Mestecky J. Humoral immune responses to microbial infections in the genital tract. Microbes Infect 4 6 (2002) 667-677
23. Neutra M.R., and Kozlowski P.A. Mucosal vaccines: the promise and the challenge. Nat Rev Immunol 6 2 (2006) 148-158
24. Nystrom-Asklin J., Adamsson J., and Harandi A.M. The adjuvant effect of CpG oligodeoxynucleotide linked to the non-toxic B subunit of cholera toxin for induction of immunity against H. pylori in mice. Scand J Immunol 67 5 (2008) 431-440
25. Ogier A., Franco M.A., Charpilienne A., Cohen J., Pothier P., and Kohli E. Distribution and phenotype of murine rotavirus-specific B cells induced by intranasal immunization with 2/6 virus-like particles. Eur J Immunol 35 7 (2005) 2122-2130
26. Velge-Roussel F., Marcelo P., Lepage A.C., Buzoni-Gatel D., and Bout D.T. Intranasal immunization with Toxoplasma gondii SAG1 induces protective cells into both NALT and GALT compartments. Infect Immun 68 2 (2000) 969-972
27. Lu S. Heterologous prime-boost vaccination. Curr Opin Immunol 21 3 (2009) 346-351
28. Medaglini D., Ciabattini A., Spinosa M.R., Maggi T., Marcotte H., Oggioni M.R., et al. Immunization with recombinant Streptococcus gordonii expressing tetanus toxin fragment C confers protection from lethal challenge in mice. Vaccine 19 15-16 (2001) 1931-1939
29. Ciabattini A., Giomarelli B., Parigi R., Chiavolini D., Pettini E., Arico B., et al. Intranasal immunization of mice with recombinant Streptococcus gordonii expressing NadA of Neisseria meningitidis induces systemic bactericidal antibodies and local IgA. Vaccine 26 33 (2008) 4244-4250
30. + T cells in nasal mucosa-associated lymphoid tissue following intranasal immunization with recombinant Streptococcus gordonii. Infect Immun 74 5 (2006) 2760-2766
31. Kotloff K.L., Wassermann S.S., Jones K.F., Livio S., Hruby D.E., Franke C.A., et al. Clinical and microbiological responses of volunteers to combined intranasal and oral inoculation with a Streptococcus gordonii carrier strain intended for future use as a group A Streptococcus vaccine. Infect Immun 73 4 (2005) 2360-2366
32. Corinti S., Medaglini D., Prezzi C., Pozzi G., and Girolomoni G. Human dendritic cells are superior to B cells at presenting a major histocompatibility complex class-II restricted heterologous antigen expressed on recombinant Streptococcus gordonii. Infect Immun 68 4 (2000) 1879-1883
33. + T lymphocytes. J Immunol 163 (1999) 3029-3036
34. Rescigno M., Citterio S., Thery C., Rittig M., Medaglini D., Pozzi G., et al. Bacterial-induced neo-biosynthesis, stabilization and surface expression of functional class I molecules in mouse dendritic cells. Proc Natl Acad Sci USA 95 9 (1998) 5229-5234
35. Ciabattini A., Cuppone A.M., Pulimeno R., Iannelli F., Pozzi G., and Medaglini D. Stimulation of human monocytes with the gram-positive vaccine vector Streptococcus gordonii. Clin Vacc Immunol 13 9 (2006) 1037-1043
36. Oggioni M.R., and Pozzi G. A host-vector system for heterologous gene expression in Streptococcus gordonii. Gene 169 (1996) 85-90
37. Shimonkevitz R., Colon S., Kappler J.W., Marrack P., and Grey H.M. Antigen recognition by H-2-restricted T cells. II. A tryptic ovalbumin peptide that substitutes for processed antigen. J Immunol 133 4 (1984) 2067-2074
38. Fremont D.H., Stura E.A., Marsumura M., Peterson P.A., and Wilson I.A. Crystal structure of an H-2Kb-ovalbumin peptide complex reveals the interplay of primary and secondary anchor positions in the major histocompatibility complex binding groove. Proc Natl Acad Sci USA 92 (1995) 2479-2483
39. Hogquist K.A., Jameson S.C., Heath W.R., Howard J.L., Bevan M.J., and Carbone F.R. T cell receptor antagonist peptides induce positive selection. Cell 76 1 (1994) 17-27
40. Barnden M.J., Allison J., Heath W.R., and Carbone F.R. Defective TCR expression in transgenic mice constructed using cDNA-based alpha- and beta-chain genes under the control of heterologous regulatory elements. Immunol Cell Biol 76 1 (1998) 34-40
41. Lyons A.B., and Parish C.R. Determination of lymphocyte division by flow cytometry. J Immunol Methods 171 1 (1994) 131-137
42. + T cells in lymph node and lung of mice with Sendai virus pneumonia by LECAM-1 and CD45RB phenotype. J Immunol 150 12 (1993) 5494-5500
43. + T cells following immunization. Eur J Immunol 25 6 (1995) 1755-1759
44. Rosen S.D. Ligands for l-selectin: homing, inflammation, and beyond. Annu Rev Immunol 22 (2004) 129-156
45. Gunn M.D., Tangemann K., Tam C., Cyster J.G., Rosen S.D., and Williams L.T. A chemokine expressed in lymphoid high endothelial venules promotes the adhesion and chemotaxis of naive T lymphocytes. Proc Natl Acad Sci USA 95 1 (1998) 258-263
46. Farstad I.N., Halstensen T.S., Lien B., Kilshaw P.J., Lazatovitis A.I., and Brandtzaeg P. Distribution of beta 7 integrins in human intestinal mucosa and organized gut-associated lymphoid tissue. Immunology 91 2 (1996) 227-237
47. Dutton R., Bradley L., and Swain S. T cell memory. Ann Rev Immunol 16 (1998) 201-223
48. Huet S., Groux H., Caillou B., Valentin H., Prieur A.M., and Bernard A. CD44 contributes to T cell activation. J Immunol 143 3 (1989) 798-801
49. + T cells. J Immunol 144 9 (1990) 3288-3295
50. Lindqvist M., Persson J., Thorn K., and Harandi A.M. The mucosal adjuvant effect of alpha-galactosylceramide for induction of protective immunity to sexually transmitted viral infection. J Immunol 182 10 (2009) 6435-6443
51. Bergquist C., Johansson E.L., Lagergard T., Holmgreen J., and Rudin A. Intranasal vaccination of humans with recombinant cholera toxin B subunit induces systemic and local antibody responses in the upper respiratory tract and the vagina. Infect Immun 65 7 (1997) 2676-2684
52. Johansson E.-L., Wassen L., Holmgreen J., Jertborn M., and Rudin A. Nasal and vaginal vaccinations have differential effects on antibody responses in vaginal and cervical secretions in humans. Infect Immun 69 12 (2001) 7481-7486
53. Rudin A., Johansson E.-L., Bergquist C., and Holmgren J. Differential kinetics and distribution of antibodies in serum and nasal and vaginal secretions after nasal and oral vaccination of humans. Infect Immun 66 7 (1998) 3390-3396
54. Brenchley J.M., Price D.A., and Douek D.C. HIV disease: fallout from a mucosal catastrophe?. Nat Immunol 7 (2006) 235-239
55. Barouch D.H. Challenges in the development of an HIV-1 vaccine. Nat Rev 455 2 (2008) 613-619
56. Shacklett B.L., Critchfield J.W., Ferre A.L., and Hayes T.L. Mucosal T-cell responses to HIV: responding at the front lines. J Int Med 265 1 (2008) 58-66
57. Bradley L., Watson S.R., and Swain S. Entry of naive CD4 T cells into peripheral lymph nodes requires l-selectin. J Exp Med 180 6 (1994) 2401-2406
58. Klinger A., Gebert A., Bieber K., Kalies K., Ager A., Bell E.B., et al. Cyclical expression of L-selectin (CD62L) by recirculating T cells. Int Immunol 21 4 (2009) 443-455
59. Sallusto F., Lenig D., Forster R., Lipp M., and Lanzavecchia A. Two subsets of memory T lymphocytes with distinct homing potentials and effector functions. Nature 401 (1999) 708-712v
60. + T cell memory. Proc Natl Acad Sci USA 104 23 (2008) 9782-9787
61. Butcher E.C., Williams M., Youngman K., Rott L., and Briskin M. Lymphocyte trafficking and regional immunity. Adv Immunol 72 (1999) 209-253
62. Csencsits K.L., Jutila M.A., and Pascual D.W. Nasal-associated lymphoid tissue: phenotypic and functional evidence for the primary role of peripheral node addressin in naive lymphocyte adhesion to high endothelial venules in a mucosal site. J Immunol 163 (1999) 1382-1389
63. Csencsits K.L., Jutila M.A., and Pascual D.W. Mucosal addressin expression and binding-interactions with naive lymphocytes vary among the cranial, oral, and nasal-associated lymphoid tissues. Eur J Immunol 32 11 (2002) 3029-3039
64. Kelly K.A., Chan A.M., Butch A., and Darville T. Two different homing pathways involving integrin beta7 and E-selectin significantly influence trafficking of CD4 cells to the genital tract following Chlamydia muridarum infection. Am J Reprod Immunol April (22) (2009) (Epub ahead of print)